In the subgroup of 24 patients with PF tumors and isolated local recurrence, CSI-RT2 showed a trend toward superior survival compared with focal RT2, with a 5-year OS of 83% versus 30%, respectively, though this did not reach statistical significance ( P = .061; Fig. 1 d).
← all excerpts
Reirradiation for Patients With Recurrent Ependymoma Across the Age Spectrum.
1
—
—